Sign in
Taking people in United StatesNo phase

Checking Heart MRI Scans Against Standard Blood Tests in Heart Disease

Compares a new heart MRI method with blood tests in adults with heart conditions.

Key facts

Who runs it
The Cleveland Clinic
Where
Cleveland, United StatesSee the site
Trial code
Registry title
Longitudinal Validation of CIRC Technologies
Status
Recruiting
People taking part
1,000 people, planned
Started
6 May 2026
Expected to end
Aug 2037
Type of study
Observational, 2 groups
Record updated
31 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults, both people with heart and blood vessel diseases and healthy people, who can have a heart MRI scan.

Age
18 years or older
Sex
Men and women

Main reasons for not taking part

  • Prisoners
  • Other reasons that rule out a heart MRI scan (CMR), based on standard MRI rules
  • People who cannot make their own decisions, for example because of dementia or cognitive disability

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Age ≥ 18 years of age
  • Provision of written informed consent

Who cannot take part

  • Decisionally impaired (e.g., dementia or cognitive disability)
  • Vulnerable populations will be excluded from this study including Prisoners
  • Other contraindications to CMR imaging to be determined by standard MRI protocols

Where in United States

  • Cleveland ClinicCleveland, United StatesContact: Research Coordinator Research CoordinatorTaking people

About the trial

What the trial wants to find out

Cardiovascular disease is the leading cause of death worldwide. Advanced cardiovascular imaging using Magnetic Resonance Imaging (MRI) has proven to be effective in providing gold standard myocardial tissue characterization. Moreover, the intrinsic advantage of MRI's lack of exposure to ionizing radiation is particularly beneficial. At the same time, blood work can be very useful in early detection of certain cardiomyopathy, such as amyloid. However, there is a lack of agreement of on which markers are the most sensitive. This multi-study will allow the unique opportunity to form a more comprehensive understanding for various cardiovascular diseases.

Read full original descriptionShow less

The study team has developed novel cardiac MRI techniques that leverages endogenous tissue properties to reveal a milieu of deep tissue phenotypes including myocardial inflammation, fibrosis, metabolism, and microstructural defects. Among these phenotypes, myocardial microstructure has proven to be most sensitive to early myocardial tissue damage and is predictive of myocardial regeneration. In this study, the investigators aim to further study the importance of cardiac microstructure revealed by MRI in patient and healthy population and compare this novel technology with conventional clinical biomarkers.

The 2 groups in the trial

  • Healthy Volunteer

    Subjects without cardiovascular disease

  • Cardiovascular Disease Patients

    Patients with known or suspected cardiovascular disease

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Longitudinal Validation of CIRC Technologies
Plain-language title
Checking Heart MRI Scans Against Standard Blood Tests in Heart DiseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
31 July 2026